{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F336-treatments-targeting-cholinergic-neurotransmission-in-ad-RCo58x3m","width":444,"version":"1.0","type":"rich","title":"336 - Treatments Targeting Cholinergic Neurotransmission in AD","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/1e00a1a7-dc39-4119-947b-e94d6d4260d9/336-d4b-text.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b1893b66-031a-45f2-b458-2b7bed6a0b6d\" height=\"200\" width=\"100%\" title=\"336 - Treatments Targeting Cholinergic Neurotransmission in AD\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Join us as we cover a set of papers published in November 2023 on treatments targeting cholinergic transmission in Alzheimer's disease. In this episode hosted by Christy, we will go over various topics, from drug discovery using synthesized compounds to drug testing of plant extracts, as well as improving drug delivery through the blood-brain barrier. Enjoy!\n\nPapers evaluating synthesized compounds (2:00) \nPapers targeting AchE (10:45)"}